Skip to Main Content

Paper Details

Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab.
Nat Cancer
4
2023
Author NameAffiliation
Arash NabbiPrincess Margaret Cancer Centre, University Health Network
Osvaldo Espin-GarciaPrincess Margaret Cancer Centre, University Health Network
Osvaldo Espin-GarciaWestern University
Osvaldo Espin-GarciaDalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto
Lynley V MarshallThe Royal Marsden NHS Foundation Trust and the Institute of Cancer Research
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
  • 1 - 11

Datasets

Release 1.2